Jay Venkatesan - Director at Elicio Therapeutics, Inc.

Issuer-level insider activity

Role
Director
Issuer ticker
ELTX on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Jay Venkatesan since 20 Sep 2025

Reported holdings for Jay Venkatesan in Elicio Therapeutics, Inc.

Form 4 holding Director

Elicio Therapeutics, Inc.

Security class
Pre-Funded Warrants
Shares / value
50,000
Estimated value
$249,500
Report date
28 Jun 2024
Price
$4.99
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Elicio Therapeutics, Inc.

Security class
Common Stock
Shares / value
179,581
Estimated value
$1,796
Report date
26 Nov 2024
Price
$0.0100
Ownership
Direct
Form 4 holding Director

Elicio Therapeutics, Inc.

Security class
Common Warrants
Shares / value
50,000
Estimated value
Report date
28 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Elicio Therapeutics, Inc.

Security class
Warrant to Purchase Common Stock
Shares / value
0
Estimated value
Report date
26 Nov 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Jay Venkatesan in Elicio Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .